A Study of Famitinib in Patients With Advanced Metastatic Renal Cell Cancer
Condition(s):Renal Cell Cancer; Metastatic Renal Cell CancerLast Updated:May 3, 2018Completed
Hide Studies Not Open or Pending
Condition(s):Renal Cell Cancer; Metastatic Renal Cell CancerLast Updated:May 3, 2018Completed
Condition(s):Advanced/ Metastatic Renal Cell CancerLast Updated:December 21, 2020Completed
Condition(s):Metastatic Renal Cell CancerLast Updated:June 29, 2023Completed
Condition(s):Clear-cell Metastatic Renal Cell CarcinomaLast Updated:February 1, 2024Completed
Condition(s):Kidney NeoplasmsLast Updated:May 6, 2022Completed
Condition(s):Kidney NeoplasmsLast Updated:January 9, 2019Completed
Condition(s):Metastatic Renal Cell CancerLast Updated:May 10, 2017Completed
Condition(s):Metastatic Renal Cell CancerLast Updated:January 10, 2019Completed
Condition(s):Metastatic Renal Cell CarcinomaLast Updated:December 21, 2020Completed
Condition(s):Metastatic Renal Cell CarcinomaLast Updated:January 11, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.